|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07K 1/00 | (2006.01) |
| C07K 16/00 | (2006.01) | ||
| A61K 38/17 | (2006.01) |
| (11) | Number of the document | 2867245 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13809853.8 |
| Date of filing the European patent application | 2013-06-28 | |
| (97) | Date of publication of the European application | 2015-05-06 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-12 |
| (46) | Date of publication of the claims translation | 2018-11-12 |
| (86) | Number | PCT/US2013/048561 |
| Date | 2013-06-28 |
| (87) | Number | WO 2014/005014 |
| Date | 2014-01-03 |
| (30) | Number | Date | Country code |
| 201261666733 P | 2012-06-29 | US |
| (72) |
NICHOLS, Dave, US
|
| (73) |
Shire Human Genetic Therapies, Inc.,
300 Shire Way, Lexington MA 02421,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Iduronato-2-sulfatazės valymas |
| PURIFICATION OF IDURONATE-2-SULFATASE |
| Payment date | Validity (years) | Amount | |
| 2024-05-21 | 12 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2023-11-22 |